Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Croda International (49GP) Share Price & Analysis

5 Followers

49GP Stock Chart & Stats

GBX 87.00GBX 0.00(0.00%)
At close: 4:30 PM GMT
82.5 p85 p87.5 p90 pJul 9Aug 20
Day’s Range
GBX 87.00 - GBX 87.00
52-Week Range
GBX 86.00 - GBX 93.00
Previous Close
GBX 87.00
Volume
N/A
Average Volume (3M)
0
Market Cap
GBP 5.04B
Enterprise Value
GBP 4849.71T
Total Cash (Recent Filing)
GBP 205.30M
Total Debt (Recent Filing)
GBP 783.20M
Price to Earnings (P/E)
64.5
Beta
0.05
Next Earnings
Feb 23, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
Nov 26, 2026
Dividend Yield
7.59%

Bulls Say, Bears Say

Bulls Say

Differentiated Specialty Ingredients

Croda’s science-led ingredients, regulatory capabilities and application expertise support premium pricing and customer co-development. These capabilities can strengthen customer retention and defend margins over time, while long-term supply relationships provide a durable foundation across consumer, life sciences and industrial markets.

Innovation-led Product Growth

Growth in new and protected products indicates that Croda is continuing to refresh its portfolio rather than relying only on mature ingredients. Successful co-creation, relaunches and biotechnology development can support differentiated offerings, improve mix and create longer-lived growth opportunities.

Margin Improvement And Transformation

The margin increase and realized transformation savings demonstrate tangible progress in improving operating efficiency. Reaching more of the savings target could provide recurring support for profitability and help offset cost pressure, while management’s reiterated margin-expansion guidance reinforces the program’s continuing relevance.

Bears Say

Muted Revenue And Earnings Trend

Broadly flat revenue limits operating leverage and makes sustained earnings improvement more dependent on pricing, mix and cost control. The sharp decline in net income also shows that bottom-line performance remains volatile, even though EBIT held up better, reducing confidence in near-term earnings quality.

Project-driven Pharma Volatility

A lumpy, project-driven Pharma Solutions business can create uneven revenue recognition and make results harder to forecast across reporting periods. H1 underperformance places greater reliance on the order book and H2 execution, increasing the risk that Life Sciences growth remains inconsistent over the next several months.

Working-capital Pressure

Elevated inventory and receivables tie up cash and can weaken the conversion of operating profit into free cash flow. Although management targets structural working-capital savings, the current outflow and factory-related build show that the benefit is not yet fully realized and remains an execution issue.

Croda International News

49GP FAQ

What was Croda International’s price range in the past 12 months?
Croda International lowest share price was 86.00 p and its highest was 93.00 p in the past 12 months.
What is Croda International’s market cap?
Croda International’s market cap is £5.04B.
When is Croda International’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Croda International overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Croda International pay dividends?
Croda International pays a Semiannually dividend of 3.3 p which represents an annual dividend yield of 7.59%. See more information on Croda International dividends here
What is Croda International’s EPS estimate?
Croda International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Croda International have?
Croda International has 499,000 shares outstanding.
Which hedge fund is a major shareholder of Croda International?
Currently, no hedge funds are holding shares in GB:49GP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology